Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 46

1.

Support of a bi-faceted role of estrogen receptor β (ERβ) in ERα-positive breast cancer cells.

Jonsson P, Katchy A, Williams C.

Endocr Relat Cancer. 2014 Jan 30;21(2):143-60. doi: 10.1530/ERC-13-0444. Print 2014 Apr.

PMID:
24192230
[PubMed - in process]
Free PMC Article
2.

Clinical instability of breast cancer markers is reflected in long-term in vitro estrogen deprivation studies.

Milosevic J, Klinge J, Borg AL, Foukakis T, Bergh J, Tobin NP.

BMC Cancer. 2013 Oct 11;13:473. doi: 10.1186/1471-2407-13-473.

PMID:
24119434
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts.

Li S, Shen D, Shao J, Crowder R, Liu W, Prat A, He X, Liu S, Hoog J, Lu C, Ding L, Griffith OL, Miller C, Larson D, Fulton RS, Harrison M, Mooney T, McMichael JF, Luo J, Tao Y, Goncalves R, Schlosberg C, Hiken JF, Saied L, Sanchez C, Giuntoli T, Bumb C, Cooper C, Kitchens RT, Lin A, Phommaly C, Davies SR, Zhang J, Kavuri MS, McEachern D, Dong YY, Ma C, Pluard T, Naughton M, Bose R, Suresh R, McDowell R, Michel L, Aft R, Gillanders W, DeSchryver K, Wilson RK, Wang S, Mills GB, Gonzalez-Angulo A, Edwards JR, Maher C, Perou CM, Mardis ER, Ellis MJ.

Cell Rep. 2013 Sep 26;4(6):1116-30. doi: 10.1016/j.celrep.2013.08.022. Epub 2013 Sep 19.

PMID:
24055055
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Ethinylestradiol is beneficial for postmenopausal patients with heavily pre-treated metastatic breast cancer after prior aromatase inhibitor treatment: a prospective study.

Iwase H, Yamamoto Y, Yamamoto-Ibusuki M, Murakami KI, Okumura Y, Tomita S, Inao T, Honda Y, Omoto Y, Iyama KI.

Br J Cancer. 2013 Sep 17;109(6):1537-42. doi: 10.1038/bjc.2013.520. Epub 2013 Sep 3.

PMID:
24002591
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

c-Src modulates estrogen-induced stress and apoptosis in estrogen-deprived breast cancer cells.

Fan P, Griffith OL, Agboke FA, Anur P, Zou X, McDaniel RE, Creswell K, Kim SH, Katzenellenbogen JA, Gray JW, Jordan VC.

Cancer Res. 2013 Jul 15;73(14):4510-20. doi: 10.1158/0008-5472.CAN-12-4152. Epub 2013 May 23.

PMID:
23704208
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Models and Mechanisms of Acquired Antihormone Resistance in Breast Cancer: Significant Clinical Progress Despite Limitations.

Sweeney EE, McDaniel RE, Maximov PY, Fan P, Jordan VC.

Horm Mol Biol Clin Investig. 2012 Feb;9(2):143-163.

PMID:
23308083
[PubMed]
Free PMC Article
7.

N-3 poly-unsaturated fatty acids shift estrogen signaling to inhibit human breast cancer cell growth.

Cao W, Ma Z, Rasenick MM, Yeh S, Yu J.

PLoS One. 2012;7(12):e52838. doi: 10.1371/journal.pone.0052838. Epub 2012 Dec 28.

PMID:
23285198
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study.

Azim HA Jr, Kroman N, Paesmans M, Gelber S, Rotmensz N, Ameye L, De Mattos-Arruda L, Pistilli B, Pinto A, Jensen MB, Cordoba O, de Azambuja E, Goldhirsch A, Piccart MJ, Peccatori FA.

J Clin Oncol. 2013 Jan 1;31(1):73-9. doi: 10.1200/JCO.2012.44.2285. Epub 2012 Nov 19.

PMID:
23169515
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Loss of pigment epithelium-derived factor: a novel mechanism for the development of endocrine resistance in breast cancer.

Jan R, Huang M, Lewis-Wambi J.

Breast Cancer Res. 2012 Nov 14;14(6):R146. doi: 10.1186/bcr3356.

PMID:
23151593
[PubMed - in process]
Free PMC Article
10.

Postoophorectomy estrogen use and breast cancer risk.

Nichols HB, Trentham-Dietz A, Newcomb PA, Titus LJ, Egan KM, Hampton JM, Visvanathan K.

Obstet Gynecol. 2012 Jul;120(1):27-36.

PMID:
22914389
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Tamoxifen-induced epigenetic silencing of oestrogen-regulated genes in anti-hormone resistant breast cancer.

Stone A, Valdés-Mora F, Gee JM, Farrow L, McClelland RA, Fiegl H, Dutkowski C, McCloy RA, Sutherland RL, Musgrove EA, Nicholson RI.

PLoS One. 2012;7(7):e40466. doi: 10.1371/journal.pone.0040466. Epub 2012 Jul 10.

PMID:
22808167
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Changing concepts: Menopausal hormone therapy and breast cancer.

Chlebowski RT, Anderson GL.

J Natl Cancer Inst. 2012 Apr 4;104(7):517-27. doi: 10.1093/jnci/djs014. Epub 2012 Mar 16. Review.

PMID:
22427684
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Involvement of ER-α36, Src, EGFR and STAT5 in the biphasic estrogen signaling of ER-negative breast cancer cells.

Zhang XT, Ding L, Kang LG, Wang ZY.

Oncol Rep. 2012 Jun;27(6):2057-65. doi: 10.3892/or.2012.1722. Epub 2012 Mar 15.

PMID:
22426783
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial.

Anderson GL, Chlebowski RT, Aragaki AK, Kuller LH, Manson JE, Gass M, Bluhm E, Connelly S, Hubbell FA, Lane D, Martin L, Ockene J, Rohan T, Schenken R, Wactawski-Wende J.

Lancet Oncol. 2012 May;13(5):476-86. doi: 10.1016/S1470-2045(12)70075-X. Epub 2012 Mar 7.

PMID:
22401913
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

The development, application and limitations of breast cancer cell lines to study tamoxifen and aromatase inhibitor resistance.

Wong C, Chen S.

J Steroid Biochem Mol Biol. 2012 Sep;131(3-5):83-92. doi: 10.1016/j.jsbmb.2011.12.005. Epub 2012 Jan 8. Review.

PMID:
22265958
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

ER and PI3K independently modulate endocrine resistance in ER-positive breast cancer.

Van Tine BA, Crowder RJ, Ellis MJ.

Cancer Discov. 2011 Sep;1(4):287-8. doi: 10.1158/2159-8290.CD-11-0192.

PMID:
22096658
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

The St. Gallen Prize Lecture 2011: evolution of long-term adjuvant anti-hormone therapy: consequences and opportunities.

Jordan VC, Obiorah I, Fan P, Kim HR, Ariazi E, Cunliffe H, Brauch H.

Breast. 2011 Oct;20 Suppl 3:S1-11. doi: 10.1016/S0960-9776(11)70287-9.

PMID:
22015273
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across time.

Ariazi EA, Cunliffe HE, Lewis-Wambi JS, Slifker MJ, Willis AL, Ramos P, Tapia C, Kim HR, Yerrum S, Sharma CG, Nicolas E, Balagurunathan Y, Ross EA, Jordan VC.

Proc Natl Acad Sci U S A. 2011 Nov 22;108(47):18879-86. doi: 10.1073/pnas.1115188108. Epub 2011 Oct 19.

PMID:
22011582
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Effects of 17β-estradiol on proliferation, cell viability and intracellular redox status in native human lens epithelial cells.

Celojevic D, Petersen A, Karlsson JO, Behndig A, Zetterberg M.

Mol Vis. 2011;17:1987-96. Epub 2011 Jul 20.

PMID:
21850173
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Proteomic analysis of pathways involved in estrogen-induced growth and apoptosis of breast cancer cells.

Hu ZZ, Kagan BL, Ariazi EA, Rosenthal DS, Zhang L, Li JV, Huang H, Wu C, Jordan VC, Riegel AT, Wellstein A.

PLoS One. 2011;6(6):e20410. doi: 10.1371/journal.pone.0020410. Epub 2011 Jun 27.

PMID:
21738574
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk